Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it

ESMO Open. 2021 Apr;6(2):100095. doi: 10.1016/j.esmoop.2021.100095. Epub 2021 Mar 24.

Authors

I Trestini¹, A Caldart¹, A Dodi¹, A Avancini², D Tregnago¹, G Sartori¹, L Belluomini¹, M Milella¹, S Pilotto³

Affiliations

¹ Medical Oncology, Department of Medicine, University of Verona Hospital Trust, Verona, Italy.
² Biomedical Sciences, Department of Medicine, University of Verona, Verona, Italy.
³ Medical Oncology, Department of Medicine, University of Verona Hospital Trust, Verona, Italy. Electronic address: sara.pilotto@univr.it.

No abstract available

Publication types

Editorial

MeSH terms

Body Composition
Humans
Immunologic Factors
Immunotherapy
Lung Neoplasms* / therapy

Substances

Immunologic Factors